Sagent Pharmaceuticals has voluntarily recalled 132,180 vials and bottles of Oxacillin for Injection, an antibiotic medication, due to a lack of assurance of sterility. The recall affects 1 gram and 2 gram vials as well as 10 gram bulk package bottles sold under the Sagent and Novaplus brands. Because these medications are administered by injection or IV, any compromise in the sterilization process could lead to serious or life-threatening infections.
Administering a non-sterile injectable medication can cause severe health complications, including systemic infections. While no injuries or adverse events have been reported to date, the lack of sterility assurance poses a significant risk to patients.
For IV or IM Use. Manufactured for Sagent Pharmaceuticals. Made in India.
For IV or IM Use. Manufactured for Sagent Pharmaceuticals. Made in India.
For Intravenous Use. Manufactured for Sagent Pharmaceuticals. Made in India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.